Brief: Nanoviricides Ultra-Broad Antiviral Activity Spectrum Of NV-387 Includes Activity Against Orthopoxvirus Family (Smallpox/Mpox)
08/05/2024 11:45
May 8 (Reuters) - NanoViricides Inc NNVC.A :
* NANOVIRICIDES INC: ULTRA-BROAD ANTIVIRAL ACTIVITY SPECTRUM
OF
NV-387 INCLUDES ACTIVITY AGAINST ORTHOPOXVIRUS FAMILY
(SMALLPOX/MPOX)
* NANOVIRICIDES INC: NV-387 POSSESSES STRONG ORTHOPOXVIRUS
ACTIVITY RELEVANT TO BOTH SEXUAL AND INHALATION MODES OF
TRANSMISSION
Source text for Eikon: ID:
Further company coverage: NNVC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NanoViricides,
See all newsExplainer: What do we know about the Bundibugyo strain of the Ebola virus?
Brief: anoViricides Signs Agreement for Orphan Drug Strategy of NV-387 for Mpox, Smallpox, and Measles
Brief: Nanoviricides Says NV-387 Shows Activity Against Measles Virus In Humanized Animal Model
Brief: Nanoviricides Co's Business Not Affected By Tariff Policies Of Us Government Or Corresponding Retaliatory Policies Of Other Governments
Brief: Nanoviricides Obtained Right Of First Refusal For All Antiviral Drug Developments